Journal of Adult Development

, Volume 12, Issue 2–3, pp 131–137 | Cite as

Neurofeedback Treatment of Depression and Anxiety

Abstract

A robust body of research documents that there are biological predispositions that often exist for depression, anxiety, and obsessive–compulsive disorder. However, new research has shown that medication is only mildly more effective than placebo in the treatment of these problems. In treating these conditions, neurofeedback (EEG biofeedback) may offer an alternative to invasive treatments such as medication, ECT, and intense levels of transcrancial magnetic stimulation. This paper reviews the neurofeedback literature with these problems, finding particularly positive research support for the treatment of anxiety disorders. New findings on the neurofeedback treatment of depression are presented.

Keywords

Neurofeedback EEG biofeedback QEEG depression anxiety OCD 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ackerman, D. L., & Greenland, S. (2002). Multivariate meta-analysis of controlled drug studies for obsessive–compulsive disorder. Journal of Clinical Psychopharmacology, 22(3), 309–317.CrossRefPubMedGoogle Scholar
  2. Allen, J. J., Iacono, W. G., Depue, R. A., & Arbisi, P. (1993). Regional electroencephalographic asymmetries in bipolar seasonal affective disorder before and after exposure to bright light. Biological Psychiatry, 33, 642–646.CrossRefPubMedGoogle Scholar
  3. Antonuccio, D. O., Danton, W. G., DeNelsky, G. Y., Greenberg, R. P., & Gordon, J. S. (1999). Raising questions about antidepressants. Psychotherapy and Psychosomatics, 68, 3–14.CrossRefPubMedGoogle Scholar
  4. Askew, J. H. (2001). The diagnosis of depression using psychometric instruments and quantitative measures of electroencephalographic activity. Unpublished doctoral dissertation, University of Tennessee.Google Scholar
  5. Baehr, E., Rosenfeld, J. P., & Baehr, R. (1997). The clinical use of an alpha asymmetry protocol in the neurofeedback treatment of depression: Two case studies. Journal of Neurotherapy, 2(3), 10–23.CrossRefGoogle Scholar
  6. Baehr, E., Rosenfeld, J. P., Baehr, R., & Earnest, P. (1998). Comparison of two EEG asymmetry indices in depressed patients vs. normal controls. International Journal of Psychophysiology, 31, 89–92.CrossRefPubMedGoogle Scholar
  7. Baehr, E., Rosenfeld, J. P., & Baehr, R. (2001). Clinical use of an alpha asymmetry neurofeedback protocol in the treatment of mood disorders: Follow-up study one to five years post therapy. Journal of Neurotherapy, 4(4), 11–18.CrossRefGoogle Scholar
  8. Chambless, D. L., Baker, M. J., Baucaom, D. H., Beutler, L. E., Calhoun, K. S., Crits-Christoph, P., et al. (1998). Update on empirically validated therapies II. The Clinical Psychologist, 51(1), 3–16.Google Scholar
  9. Chambless, D., & Hollon, S. D. (1998). Defining empirically supported therapies. Journal of Consulting and Clinical Psychology, 66, 7–18.CrossRefPubMedGoogle Scholar
  10. Davidson, R. J. (1992). Emotion and affective style: Hemispheric substrates. Psychological Science, 3, 39–43.Google Scholar
  11. Davidson, R. J. (1995). Cerebral asymmetry, emotion and affective style. In R. J. Davidson & K. Hugdahl (Eds.), Brain asymmetry (pp. 361–387). Boston: MIT Press.Google Scholar
  12. Davidson, R. J. (1998a). Affective style and affective disorders: Perspectives from affective neuroscience. Cognition and Emotion, 12, 307–330.Google Scholar
  13. Davidson, R. J. (1998b). Anterior electrophysiological asymmetries, emotion, and depression: Conceptual and methodological conundrums. Psychophysiology, 35, 607–614.Google Scholar
  14. Dawson, G., Grofer Klinger, L., Panagiotides, H., Hill, D., & Spieker, S. (1992). Frontal lobe activity and affective behavior of infants of mothers with depressed symptoms. Child Development, 63, 725–737.PubMedGoogle Scholar
  15. Dawson, G., Grofer, K. L., Panagiotides, H., Spieker, S., & Frey, K. (1992). Infants of mothers with depressed symptoms: Electroencephalographic and behavioral findings related to attachment status. Development and Psychopathology, 4, 67–80.CrossRefGoogle Scholar
  16. Duffy, F. H. (2000). Editorial: The state of EEG biofeedback therapy (EEG operant conditioning) in 2000: An editor's opinion. Clinical Electroencephalography, 31(1), v–viii.Google Scholar
  17. Egner, T., & Gruzelier, J. H. (2003). Ecological validity of neurofeedback: Modulation of slow wave EEG enhances musical performance. NeuroReport, 14(9), 1221–1224.PubMedGoogle Scholar
  18. Field, T., Fox, N., Pickens, J., & Nawrocki, R. (1995). Relative right frontal EEG activation in 3- to 6-month-old infants of “depressed” mothers. Developmental Psychology, 26, 7–14.Google Scholar
  19. Fuchs, T., Birbaumer, N., Lutzenberger, W., Gruzelier, J. H., & Kaiser, J. (2003). Neurofeedback treatment for attention deficit/hyperactivity disorder in children: A comparison with methylphenidate. Applied Psychophysiology and Biofeedback, 28, 1–12.CrossRefPubMedGoogle Scholar
  20. Garrett, B. L., & Silver, M. P. (1976). The use of EMG and alpha biofeedback to relieve test anxiety in college students. Chapter in I. Wickramasekera (Ed.), Biofeedback, Behavior Therapy, and Hypnosis, Chicago: Nelson-Hall.Google Scholar
  21. Goodman, W. K., McDougle, C. J., & Price, L. H. (1992). Pharmacotherapy of obsessive compulsive disorder. Journal of Clinical Psychiatry, 53(Suppl), 29–37.PubMedGoogle Scholar
  22. Gotlib, I. H., Ranganath, C., & Rosenfeld, J. P. (1999). Frontal EEG alpha asymmetry, depression, and cognitive functioning. Cognition and Emotion, 12, 449–478.Google Scholar
  23. Greenberg, R. P., Bornstein, R. F., Greenberg, M. D., & Fisher, S. (1992). A meta-analysis of antidepressant outcome under “blinder” conditions. Journal of Consulting and Clinical Psychology, 60, 664–669.PubMedGoogle Scholar
  24. Hammond, D. C. (2000) Neurofeedback treatment of depression with the Roshi. Journal of Neurotherapy, 4(2), 45–56.Google Scholar
  25. Hammond, D. C. (2003). QEEG-guided neurofeedback in the treatment of obsessive–compulsive disorder. Journal of Neurotherapy, 7(2), 25–52.Google Scholar
  26. Hammond, D. C. (2004). Treatment of obsessional OCD with neurofeedback. Biofeedback, 32, 9–12.Google Scholar
  27. Heller, W., Etienne, M. A., & Miller, G. A. (1995). Patterns of perceptual asymmetry in depression and anxiety: Implications for neuropsychological models of emotion and psychopathology. Journal of Abnormal Psychology, 104, 327–333.CrossRefPubMedGoogle Scholar
  28. Heller, W., Nitschke, J. B., Etienne, M. A., & Miller, G. A. (1997). Patterns of regional brain activity differentiate types of anxiety. Journal of Abnormal Psychology, 106(3), 376–385.CrossRefPubMedGoogle Scholar
  29. Henriques, J. B., & Davidson, R. J. (1991). Left frontal hypoactivation in depression. Journal of Abnormal Psychology, 100, 534–545.CrossRefGoogle Scholar
  30. Jones, N. A., Field, T., Fox, N. A., Lundy, B., & Davalos, M. (1997). EEG activation in 1-month-old infants of depressed mothers. Developmental Psychopathology, 9, 491–505.CrossRefGoogle Scholar
  31. Khan, A., Khan, S., & Brown, W. A. (2002). Are placebo controls necessary to test new antidepressants and anxiolytics? International Journal of Neuropsychopharmacology, 5, 193–197.PubMedGoogle Scholar
  32. Kirsch, I., Moore, T. J., Scoboria, A., & Nicholls, S. S. (2002). The emperor's new drugs: An analysis of antidepressant medication data submitted to the U.S. Food and Drug Administration. Prevention and Treatment, 5, Article 23. Available online at http://www.journals.apa.org/prevention/volume5/pre0050023a.html.
  33. Kirsch, I., & Sapirstein, G. (1998). Listening to Prozac but hearing placebo: A meta-analysis of antidepressant medication. Prevention and Treatment, 1, Article 2.Google Scholar
  34. Kirsch, I., Scoboria, A., & Moore, T. J. (2002). Antidepressants and placebos: Secrets, revelations, and unanswered questions. Prevention and Treatment, 5, Article 33.Google Scholar
  35. Kotchoubey, B., Strehl, U., Uhlmann, C., Holzapfel, S., Konig, M., Froscher, W., Blankenhorn, V., & Birbaumer, N. (2001). Modification of slow cortical potentials in patients with refractory epilepsy: A controlled outcome study. Epilepsia, 42(3), 406–416.CrossRefPubMedGoogle Scholar
  36. Kwon, J. S., Youn, T., & Jung, H. Y. (1996). Right hemisphere abnormalities in major depression: Quantitative electroencephalographic findings before and after treatment. Journal of Affective Disorders, 40, 169–173.CrossRefPubMedGoogle Scholar
  37. Moncrieff, J. (2001). Are antidepressants overrated? A review of methodological problems in antidepressant trials. Journal of Nervous and Mental Disease, 189(5), 288–295.PubMedGoogle Scholar
  38. Moore, N. C. (2000). A review of EEG biofeedback treatment of anxiety disorders. Clinical Electroencephalography, 31(1), 1–6.PubMedGoogle Scholar
  39. Passini, F. T., Watson, C. G., Dehnel, L., Herder, J., & Watkins, B. (1977). Alpha wave biofeedback training therapy in alcoholics. Journal of Clinical Psychology, 33(1), 292–299.PubMedGoogle Scholar
  40. Peniston, E. G., & Kulkosky, P. J. (1991). Alpha-theta brainwave neuro-feedback therapy for Vietnam veterans with combat-related post-traumatic stress disorder. Medical Psychotherapy, 4, 47–60.Google Scholar
  41. Peniston, E. G., Marrinan, D. A., Deming, W. A., & Kulkosky, P. J. (1993). EEG alpha-theta synchronization in Vietnam theater veterans with combat-related post-traumatic stress disorder and alcohol abuse. Advances in Medical Psychotherapy, 6, 37–50.Google Scholar
  42. Rosenfeld, J. P., Cha, G., Blair, T., & Gotlib, I. (1995). Operant biofeedback control of left-right frontal alpha power differences. Biofeedback and Self-Regulation, 20, 241–258.CrossRefPubMedGoogle Scholar
  43. Rosenfeld, J. P. (1997). EEG biofeedback of frontal alpha asymmetry in affective disorders. Biofeedback, 25(1), 8–25.Google Scholar
  44. Rossiter, T. R., & La Vaque, T. J. (1995). A comparison of EEG biofeedback and psychostimulants in treating attention deficit/hyperactivity disorders. Journal of Neurotherapy, 1, 48–59.CrossRefGoogle Scholar
  45. Sterman, M. B. (2000). Basic concepts and clinical findings in the treatment of seizure disorders with EEG operant conditioning. Clinical Electroencephalography, 31(1), 45–55.PubMedGoogle Scholar
  46. Walach, H., & Maidhof, C. (1999). Is the placebo effect dependent on time? A meta-analysis. In I. Kirsch (Ed.), How Expectancies Shape Experience (pp. 321–332). Washington, DC: American Psychological Association Press.Google Scholar
  47. Watson, C. G., Herder, J., & Passini, F. T. (1978). Alpha biofeedback therapy in alcoholics: An 18-month follow-up. Journal of Clinical Psychology, 34(2), 765–769.PubMedGoogle Scholar
  48. Wiedemann, G., Pauli, P., Dengler, W., Lutzenberger, W., Birbaumer, N., & Buckkremer, G. (1999). Frontal brain asymmetry as a biological substrate of emotions in patients with panic disorders. Archives of General Psychiatry, 56, 78–84.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  1. 1.Department of Physical Medicine and RehabilitationUniversity of Utah School of MedicineSalt Lake City
  2. 2.Department of Physical Medicine and RehabilitationUniversity of Utah School of MedicineSalt Lake City

Personalised recommendations